Jing Xu M.D., Ph.D.

Dr. Jing Xu got her MD degree from Peking Union Medical College, Beijing, China and her PhD degree in Pharmacology at Johns Hopkins University School of Medicine. She completed her clinical pathology residency training at Cedars-Sinai Medical Center (PGY1) and UT Southwestern Medical Center (PGY2 and 3). She also did her molecular pathology fellowship training at UT Southwestern. Dr. Xu is board certified in clinical pathology and molecular genetic pathology.

Key Publications

Xu J, Kirtek T, Xu Y, Zheng H, Yao H, Ostman E, Oliver D, Malter JS. Gagan J, SoRelle JA. Digital Droplet PCR for SARS-CoV-2 resolves Borderline cases. Am J Clin Pathol. 2021

Xu J, Westfall DE, Lopategui JR. “Indeterminate” UroVysion Fluorescence In Situ Hybridization Results: Clinical Implications of Diagnostic Terminology. Am J Clin Pathol. 2021

Xu J, Crossley E, Wagenfuehr J, Mitui M, Londin E, Patel K, Park JY. Control Charting Genomic Data. J Appl Lab Med. 2020

Narasimhan M, Mahimainathan L, Araj E , Clark AE, Markantonis J, Green A, Xu J, SoRelle JA , Alexis C, Fankhauser K, Parikh H, Wilson K, Reczek A, Kopplin N, Yekkaluri S, Jyoti Balani , Thomas A, Singal A, Sarode R, Muthukumar A. Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays in infected, recovered, and vaccinated groups. J Clin Microbiol. 2021.

Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS, Roberts RO, Machulda MM, Jack CR Jr, Petersen RC, Dage JL. Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 2018.